Search research articles
Contact Us
Filters
Showing results (101-110 of 253) with videos related to
Page
of 26
Sort By:
Endocrine Journal
|
July 28, 2015
A case of insulinoma with non-alcoholic fatty liver disease: Roles of hyperphagia and hyperinsulinemia in pathogenesis of the disease
Mariyo Rokutan, Daisuke Yabe, Izumi Komoto, et al.
Nutrients
|
February 27, 2026
D-Allulose Reduces Weight More Persistently than Oral Semaglutide While Both Equally Elevate Grip Strength in Diet-Induced Obese Mice
Yermek Rakhat, Seiya Banno, Dauren Zhantleu, et al.
Journal of Diabetes Investigation
|
April 8, 2026
Life-threatening acute complications persist among individuals with type 1 diabetes in Japan: A nationwide registry-based cross-sectional study
Daisuke Chujo, Akihisa Imagawa, Junnosuke Miura, et al.
Diabetes, Obesity & Metabolism
|
October 8, 2021
Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials
Yuichiro Yamada, Daisuke Yabe, Christin Løth Hertz, et al.
Diabetes Research and Clinical Practice
|
September 16, 2008
A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion
Daisuke Yabe, Akira Kuroe, Michihiro Ohya, et al.
Diabetology International
|
July 3, 2025
Longitudinal monitoring of urinary C-peptide levels following discontinuation of sacubitril/valsartan in a type 2 diabetes patient: a case report and literature review
Keiichiro Kondo, Hiroto Minamino, Takaaki Murakami, et al.
The Journal of Biological Chemistry
|
October 18, 2003
Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol
Navdar Sever, Bao-Liang Song, Daisuke Yabe, et al.
Journal of Diabetes Investigation
|
February 3, 2022
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials
Daisuke Yabe, Srikanth Deenadayalan, Hiroshi Horio, et al.
Lancet (London, England)
|
March 1, 2026
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
Julio Rosenstock, Daisuke Yabe, David Cox, et al.
Diabetology International
|
February 26, 2019
Correction to: Japanese Clinical Practice Guideline for Diabetes 2016
Masakazu Haneda, Mitsuhiko Noda, Hideki Origasa, et al.
Page
of 26
Search research articles
Search
Showing results (101-110 of 253) with videos related to
Sort By:
Page
of 26
Endocrine Journal
|
July 28, 2015
A case of insulinoma with non-alcoholic fatty liver disease: Roles of hyperphagia and hyperinsulinemia in pathogenesis of the disease
Mariyo Rokutan, Daisuke Yabe, Izumi Komoto, et al.
Nutrients
|
February 27, 2026
D-Allulose Reduces Weight More Persistently than Oral Semaglutide While Both Equally Elevate Grip Strength in Diet-Induced Obese Mice
Yermek Rakhat, Seiya Banno, Dauren Zhantleu, et al.
Journal of Diabetes Investigation
|
April 8, 2026
Life-threatening acute complications persist among individuals with type 1 diabetes in Japan: A nationwide registry-based cross-sectional study
Daisuke Chujo, Akihisa Imagawa, Junnosuke Miura, et al.
Diabetes, Obesity & Metabolism
|
October 8, 2021
Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials
Yuichiro Yamada, Daisuke Yabe, Christin Løth Hertz, et al.
Diabetes Research and Clinical Practice
|
September 16, 2008
A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion
Daisuke Yabe, Akira Kuroe, Michihiro Ohya, et al.
Diabetology International
|
July 3, 2025
Longitudinal monitoring of urinary C-peptide levels following discontinuation of sacubitril/valsartan in a type 2 diabetes patient: a case report and literature review
Keiichiro Kondo, Hiroto Minamino, Takaaki Murakami, et al.
The Journal of Biological Chemistry
|
October 18, 2003
Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol
Navdar Sever, Bao-Liang Song, Daisuke Yabe, et al.
Journal of Diabetes Investigation
|
February 3, 2022
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials
Daisuke Yabe, Srikanth Deenadayalan, Hiroshi Horio, et al.
Lancet (London, England)
|
March 1, 2026
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
Julio Rosenstock, Daisuke Yabe, David Cox, et al.
Diabetology International
|
February 26, 2019
Correction to: Japanese Clinical Practice Guideline for Diabetes 2016
Masakazu Haneda, Mitsuhiko Noda, Hideki Origasa, et al.
Page
of 26